Adamis Pharmaceuticals (NASDAQ:ADMP) Stock Crosses Below 200 Day Moving Average of $0.21

Adamis Pharmaceuticals Co. (NASDAQ:ADMP – Get Rating)’s share price passed below its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of $0.21 and traded as low as $0.14. Adamis Pharmaceuticals shares last traded at $0.14, with a volume of 919,210 shares changing hands.

Analyst Ratings Changes

Separately, StockNews.com started coverage on Adamis Pharmaceuticals in a research report on Friday. They issued a “hold” rating on the stock.

Adamis Pharmaceuticals Stock Performance

The business has a 50 day moving average of $0.21 and a two-hundred day moving average of $0.21.

Institutional Investors Weigh In On Adamis Pharmaceuticals

An institutional investor recently raised its position in Adamis Pharmaceuticals stock. State Street Corp boosted its holdings in shares of Adamis Pharmaceuticals Co. (NASDAQ:ADMP – Get Rating) by 13.1% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 475,373 shares of the specialty pharmaceutical company’s stock after buying an additional 55,168 shares during the period. State Street Corp owned approximately 0.32% of Adamis Pharmaceuticals worth $271,000 as of its most recent filing with the Securities and Exchange Commission (SEC). 8.57% of the stock is currently owned by institutional investors.

Adamis Pharmaceuticals Company Profile

(Get Rating)

Adamis Pharmaceuticals Corp. is a biopharmaceutical company, which engages in the discovery, development, and sale of pharmaceutical, specialty biopharmaceutical, and other drug products. The company provides products in various therapeutic areas, including allergy, respiratory, opioid overdose, and erectile dysfunction markets.